Skip to content

Xbrane Biopharma AB Sustainability Reports

Xbrane Biopharma AB is a biotechnology company specialized in the development and manufacturing of biosimilars. The company leverages a patented high-yield protein expression platform to produce affordable biological drugs for patients globally.

Sector: Manufacturing

Country: Sweden

Exchange: Nasdaq Stockholm

LEI: 5493008DKD05APTKQO39

9 reports from 2016 to 2025